Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Morristown, New Jersey
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 656 filings
- On EDGAR
- CIK 1422142
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 73
News 8 of 113
Prospectuses and Registrations 8 of 49
- S-3 Shelf registration statement May 29, 2026
- S-8 Registration statement for an employee plan Mar 12, 2026
- 424B5 Prospectus supplement for an offering Apr 25, 2025
- S-3 Shelf registration statement Mar 31, 2025
- S-8 Registration statement for an employee plan Mar 28, 2025
- 424B5 Prospectus supplement for an offering May 3, 2024
- S-8 Registration statement for an employee plan Feb 12, 2024
- S-3 Shelf registration statement Feb 12, 2024
Proxies 8 of 32
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Feb 19, 2025
- DEFA14A Extra proxy material Feb 18, 2025
- DEFA14A Extra proxy material Feb 5, 2025
- DEFM14A Jan 31, 2025
Ownership 8 of 338
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Jul 30, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
- 4 Insider reported a trade Jun 15, 2026
Other 8 of 51
- EFFECT Notice that a registration became effective Jun 9, 2026
- ARS Annual report sent to shareholders Apr 28, 2026
- UPLOAD Comment letter from SEC staff May 22, 2025
- CORRESP Reply to SEC staff May 13, 2025
- UPLOAD Comment letter from SEC staff May 7, 2025
- ARS Annual report sent to shareholders Apr 28, 2025
- EFFECT Notice that a registration became effective Apr 8, 2025
- CORRESP Reply to SEC staff Apr 4, 2025
Everything here comes from Whitehawk Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.